ACTI Bootcamp: NSW Regional Workshop Program

China is the second largest and fastest growing medtech and pharma market. Over the last few years, this has resulted in increasing investment interest by Chinese medtech and pharma into the Australian healthcare and medical research sector. The ACTI China Market Commercialisation Pathway workshop will tangibly provide research entrepreneurs and executives of healthtech companies the strategic and practical knowledge in order to maximise the ability to leverage innovations and seize the enormous opportunity the Chinese Market represents.

The aim of this workshop is to provide the tools and insight in order to cater to the Chinese market, no matter what level the participants are within their product development/innovation pipeline. Additionally, it will provide insight into the identification of opportunities and how to leverage and adapt existing innovations/concepts, prototypes and inventions so they are suitably attractive to the China market.

The workshop will incorporate sessions on developing a market entry strategy; successful partnering approaches; regulatory pathways; distribution and marketing; market risks; common pitfalls; and key success factors for Australian healthcare products, technologies and services into China. Critically, this workshop will also focus on the cultural and mentality differences that exist between Australian and Chinese business interactions.